Delivery Order SPE2DB22D1106-SPE2DB24FEFB2
- Not listed
- This $21,204.72 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) on May 29, 2024. The contract is for the supply of 4,564,741,632 units of HERCEPTIN 150 MG VIALS, a critical pharmaceutical product, with a period of performance through June 20, 2024. This delivery order is placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the...
- The U.S. government has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,942,502 units of Herceptin 150 mg vials. The contract has a ceiling value of $8,835.30 and a period of performance through April 2, 2024. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense's military treatment programs and facilities. Amerisourcebergen Drug...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $3,534.12 contract is for the provision of 4564204008 HERCEPTIN 150 MG vials to support Department of Defense military treatment programs and facilities. The award has an ultimate completion date of April 29, 2024 and does not utilize any small...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,068.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide HERCEPTIN 150 MG VIALS. The delivery order is part of Amerisourcebergen Drug Corp's larger, single-award indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4,563,738,045 units of HERCEPTIN 150 mg vials, a specialty pharmaceutical product, with a completion date of March 14, 2024 and a potential value of $13,252.95. The contract does not have...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor, for the provision of 150 mg vials of the pharmaceutical drug Herceptin. The delivery order has a completion date of March 22, 2024 and a potential value of $8,835.30. Amerisourcebergen Drug Corp, a for-profit organization, is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HERCEPTIN HYLECTA 600MG-10,000 5ML. The contract has a potential value of $10,669.36 and a performance period through March 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which is not associated with any set-aside designation. This contract is part of...
- This is a firm fixed-price delivery order (SPE2DB22D1106|SPE2DB24FEEW5) awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of 4,563,970,501 units of the drug Herceptin (150 mg vials) at a ceiling value of $21,204.72. The delivery order falls under a larger, single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,875,621 units of the biologic drug Herceptin Hylecta (600mg-10,000 5mL). The fixed-price delivery order, valued at $18,700.96, has a completion date of May 31, 2023. It is not associated with a set-aside program. Amerisourcebergen, a for-profit organization, is the prime contractor and holds a larger $999,999,999 Indefinite Delivery...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 150 mg Herceptin vials, a specialty medication, with a potential value of $7,951.77 and a completion date of February 23, 2024. The contract is not set aside for any particular business type....
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEFB2Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Herceptin 150 mg vials. The contract has a ceiling value of $21,204.72 and a performance period through April 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is issued under a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 3/15/24 |